Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco || Katalyst HLS ||

Mike was told in the fall of 2010 that Pfizer was closing the Allergy & Respiratory diseases programs and his own role as the CSO of this group was being eliminated. Rather than seek employment elsewhere, Mike had others ideas.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s